Clinical trials
Kidney Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Active, not recruiting | 12 |
| Recruiting | 9 |
| Unknown status | 7 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Takeda | 3 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Genzyme, a Sanofi Company | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| University of Edinburgh | 2 |
| University of Leicester | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 63 |
| Renal Insufficiency, Chronic | 17 |
| Glomerulonephritis | 8 |
| Diabetes Mellitus, Type 2 | 6 |
| Glomerulonephritis, IGA | 6 |
| Kidney Failure, Chronic | 6 |
| Renal Insufficiency | 6 |
| Urologic Diseases | 6 |
| Diabetes Mellitus | 5 |
| Nephritis | 5 |
Trials
Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.